antibiot manag cystic fibrosi cystic fibrosi common autosom recess disord great britain central europ north america affect 1 2000 live born children doe antibiot treatment cystic fibrosi differ treatment respiratori infect condit cystic fibrosi patient onli suffer progress deterior respiratori function often ha danger complic condit culmin superinfect highli resist organ basic principl antibiot therapi must rigidli appli cystic fibrosi first principl identifi pathogen suscept antibiot second principl ensur chosen antibiot reach site infect third principl antibiot therapi ought complement immunolog defenc patient fourth principl therapi must given without first decid upon criteria accept indic clinic improv